NASDAQ
Gene Biotherapeutics, Inc. (CRXM) has a interest coverage ratio of -21.99x as of Friday, May 29, 2026. This represents a 41.84% increase compared to its 12-month average of -37.80x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.